Nicole Urken is research director, Mad Money and Jim Cramer's researcher at TheStreet. Nicole analyzes stocks and develops a strategic macro outlook, which she incorporates into segment ideas for CNBC's "Mad Money" and supports Jim's other endeavors including "Squawk on the Street" and RealMoney.com. Nicole also writes the "Inside the Madness" blog on cnbc.com.
Previously, she worked as an investment banking analyst for the Industrials Group in Goldman Sachs' New York office. Born and raised in Princeton, New Jersey, Nicole graduated with honors from Harvard College, where she served as executive editor of The Harvard Crimson.
Follow Nicole Urken on Twitter @nicoleurken.
Cramer looks at opportunities presented by Angie’s List and JDS Uniphase.
As the Alibaba IPO nears, Cramer expects a slew of stocks to selloff.
Cramer always says that investors need to watch the market like a hawk.
Cramer thinks pros are so eager to buy Alibaba they’re willing to throw away perfectly good stocks.
Grab the latest CNBC gear from the NBCUniversal Store!
Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.
You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.
Check out what Cramer has to say about a busy week ahead in this recap of Friday's "Mad Money."
Check out some of Jim Cramer's proprietary stock calls from Thursday's "Mad Money" in this quick recap.
Mad Money host Jim Cramer provides a game plan for investors on how to play a mixed market. Cramer says Apple is a franchise player and Dow Chemical is one of the most resourceful competitors in the game.